The blog

The JellyFil Blog

This bottle prints a full Supplement Facts panel while its own advertising prints a shorter list, and that gap is the most interesting thing about it. Three of these five articles are about the distance between an advertisement and a label. The fourth is about the timeline. The fifth costs the product something, which is why the other four are worth reading.

All five articles

Nine On The Bottle, Six In The Advert: How To Count An Ingredient List

The advertising names six plants and the panel names nine. The three it drops are the three with the most to say.

Label literacy · 8 min read

What Eighty-Two Milligrams Buys: Blend Totals Against Trial Doses

A blend total hides the split and publishes a ceiling. The ceiling is the useful number, and here is what it rules out.

Dose arithmetic · 9 min read

The Plant The Advert Leaves Out: Horny Goat Weed And The Enzyme

Of four plants screened against human PDE5, only Epimedium was active. It is the one the sales page drops.

Ingredient deep dive · 9 min read

Why Week One Feels Like Nothing, And What To Watch Instead

The trials behind these plants moved at six to twelve weeks. Week one answers a different question, and it is a useful one.

Realistic expectations · 8 min read

A Gummy Is A Format Decision, And It Costs Something

The format buys the routine and spends the payload. Both halves are worth stating before you choose.

The format · 8 min read

How these are put together

Every article carries the JellyFil Team byline, a visible last-updated date, and a short list of public sources you can open and read for yourself. Several are unflattering to the product beside them, because a blog that only agrees with the bottle is an advertisement with subheadings. Corrections go to contact@Jellyfile.com and move the review date forward.

Where to start

If you are comparing two bottles in a shop, start with nine on the bottle, six in the advert. It takes ninety seconds and it changes what a front label means.
If a product page has quoted a study at you, start with what eighty-two milligrams buys. It is the arithmetic that study invites and rarely survives.
If you take a nitrate or a prescription for erectile difficulty, start with the plant the advert leaves out, and read the medical note at the foot of it before anything else on this website.
If you are two weeks in and disappointed, start with why week one feels like nothing.
If you are deciding between a gummy and a capsule, start with the format article, which is the only one here that is not about this bottle at all.

What these articles do not do

None of them attributes a milligram figure to any single plant in this bottle, because the panel prints one figure for the whole blend and this desk does not estimate. None of them describes the product as a treatment for anything. And none of them repeats the three sentences from the seller’s own pages that the about page records as refused.

Who writes the JellyFil pages, and where the numbers come from

This desk sells the bottle and also writes about it. That is a conflict of interest, and naming it first is cheaper than being caught by it, so the working rule here is that nothing gets printed which a reader cannot go and check. The bottle artwork supplies the panel, the routine and the count, and the panel is reproduced on this website exactly as it is printed, including the three plants the advertising leaves out. It supplies one figure for the whole blend and no figure for any single plant, and none is invented to fill the space: what sits there instead is the amount each published trial gave people, lifted out of the record it belongs to and linked straight back to it. Spotted something wrong? contact@Jellyfile.com reaches the people who wrote it, the page changes, and the date below moves with it. Last reviewed September 2026.